BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 16769986)

  • 1. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
    Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
    J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer.
    Bekelman JE; Rosenzweig KE; Bach PB; Schrag D
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):492-9. PubMed ID: 16814952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
    Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
    Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage IB non-small cell lung cancer: impact of the number of lymph nodes examined on survival].
    Cerón J; Peñalver JC; Jordá C; Padilla J
    Arch Bronconeumol; 2009 Feb; 45(2):87-91. PubMed ID: 19232270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years' experience in a single institute.
    Karakoyun-Celik O; Yalman D; Bolukbasi Y; Cakan A; Cok G; Ozkok S
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):433-9. PubMed ID: 19386425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.